All GLG News Analyses Filed Under: Legal Issues

Can a supplier of a product limit how you use that product? That is the basic question in my opinion in this case. ATT and T-Mobile have placed restrictions on products by requiring a service contract that allows use of a product only on their network. What about other products?

Will federal preemption be used as a shield from liability for drug companies and many other entities?Is Federal protection becoming an oxymoron?

The last time RIMM faced a serious patent challenge, both the patent  bar and the investment community were sharply focused on the fight and its long-run implications for patent law as well as RIMM itself.  This time, the Visto case looms, but with very little hang-wringing apparent in either...

The market applauded this week when TSRA announced a patent settlement with one of the many firms that stand accused of infringing Tessera's beseiged patent portfolio.  But no one ought count their chickens yet.  The path toward championing TSRA's patent portfolio is path that favors...

The on-going wheel-bonusing litigation between Bally and IGT will come to a head this November; and, thanks to a recent ruling by the judge, the same jury will hear not only the patent issues but also BYI's antitrust allegations.

Commentators continue to predict that settlement is around the corner for NOK and QCOM; but the reality of the Delaware case is that it is just another bend in the road, rather than being any serious settlement opportunity.

Bally's technologies has been able to achieve great success by innovating with unique techonologies and one of a kind ideas and product offerings.  In the gaming industry Bally has a special reputation with name regonition and a reliability that is second to none.

Use of regulatory rule making and Federal preemption increases the risk and exposure of people to corporate malfeasance without appropriate oversight. Regulatory Agencies do not have the ability to audit the detailed actions of corporations therefore its regulatory oversight does not act as a sufficient...

This ruling could be an early indication that we are not ready for automatic Federal preemption.Is this ruling based on sound legal precedent or the the sign of our times with a struggling market?

This bill would limit innovative health insurance products which could actually lower rates for consumers.